147 related articles for article (PubMed ID: 15500126)
1. [Minimal change nephrotic syndrome].
Uda S; Nakayama T; Hirose M; Yoshimura A
Nihon Rinsho; 2004 Oct; 62(10):1829-36. PubMed ID: 15500126
[TBL] [Abstract][Full Text] [Related]
2. [Minimal change nephrotic syndrome : new insights into disease pathogenesis].
Audard V; Lang P; Sahali D
Med Sci (Paris); 2008 Oct; 24(10):853-8. PubMed ID: 18950582
[TBL] [Abstract][Full Text] [Related]
3. [Minimal change nephrotic syndrome complicated with recurrence of malignant thymoma: an interesting case with remission due to steroid therapy of both nephrotic syndrome and thymoma].
Fukuda A; Sato Y; Iwatsubo S; Komatsu H; Nishiura R; Fukudome K; Yamada K; Hara S; Fujimoto S; Kitamura K
Nihon Jinzo Gakkai Shi; 2009; 51(2):130-7. PubMed ID: 19378799
[TBL] [Abstract][Full Text] [Related]
4. [Minimal change nephrotic syndrome: Pathogenesis, pathophysiology and therapy].
Wakui H; Komatsuda A
Nihon Rinsho; 2006 Feb; 64 Suppl 2():408-12. PubMed ID: 16523923
[No Abstract] [Full Text] [Related]
5. [Case of goodpasture syndrome associated with minimal change nephrotic syndrome (MCNS) in a patient with rheumatoid arthritis (RA)].
Takeda Y; Abe A; Toki T; Komaba H; Abe T; Umezu M; Joh K; Fukagawa M
Nihon Jinzo Gakkai Shi; 2009; 51(7):897-903. PubMed ID: 19928565
[TBL] [Abstract][Full Text] [Related]
6. [A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
Yoshimoto K; Wada T; Iwata Y; Sakai N; Shimizu M; Furuichi K; Yokoyama H; Kobayashi K
Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):640-3. PubMed ID: 11195400
[TBL] [Abstract][Full Text] [Related]
7. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
[TBL] [Abstract][Full Text] [Related]
8. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.
van den Berg JG; van den Bergh Weerman MA; Assmann KJ; Weening JJ; Florquin S
Kidney Int; 2004 Nov; 66(5):1901-6. PubMed ID: 15496161
[TBL] [Abstract][Full Text] [Related]
9. [Minimal change nephrotic syndrome].
Hirayama K; Kobayashi M
Nihon Jinzo Gakkai Shi; 2010; 52(7):882-7. PubMed ID: 21077335
[No Abstract] [Full Text] [Related]
10. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
[TBL] [Abstract][Full Text] [Related]
11. [Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].
Pruna A; Barka A; Nochy D; Hauet T; Boulanger H; Landais P
Nephrologie; 1997; 18(3):95-101. PubMed ID: 9297136
[TBL] [Abstract][Full Text] [Related]
12. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
Aggarwal N; Batwara R; McCarthy ET; Sharma R; Sharma M; Savin VJ
Am J Kidney Dis; 2007 Nov; 50(5):826-9. PubMed ID: 17954296
[TBL] [Abstract][Full Text] [Related]
13. Minimal-change nephrotic syndrome associated with systemic lupus erythematosus.
Makino H; Haramoto T; Shikata K; Ogura T; Ota Z
Am J Nephrol; 1995; 15(5):439-41. PubMed ID: 7503146
[TBL] [Abstract][Full Text] [Related]
14. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
Branten AJ; Wetzels JF
Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2832-8. PubMed ID: 10065257
[TBL] [Abstract][Full Text] [Related]
15. [A case of minimal change nephrotic syndrome manifesting acute renal failure in the course of systemic lupus erythematosus].
Sugimoto T; Yamasaki Y; Kobayashi M; Usui H; Matsuda M; Ohishi T; Ichikawa H; Nakamura Y; Nagake Y; Makino H
Nihon Jinzo Gakkai Shi; 2002; 44(5):476-82. PubMed ID: 12216481
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
17. [Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome].
Shimizu H; Saitoh T; Osaki Y; Yamane A; Gohda F; Irisawa H; Yokohama A; Uchiumi H; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
Rinsho Ketsueki; 2007 Jun; 48(6):514-7. PubMed ID: 17633102
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
[TBL] [Abstract][Full Text] [Related]
19. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
Eguchi A; Takei T; Yoshida T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
